The Pharma Letter3h
The week in pharma: action, reaction and insight – week to November 22
Research news last week included US biotech Fate releasing early data for its FT819 in the treatment of systemic lupus ...
The Pharma Letter22h
Otsuka gains global licensing rights from Ionis to ulefnersen
Japanese mid-size drugmaker Otsuka Pharmaceutical announced that it has entered into an exclusive worldwide licensing ...
The Pharma Letter1d
BRIEF—Halozyme withdraws non-binding offer for Evotec
Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per ...